{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:40:11Z","timestamp":1738197611460,"version":"3.34.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.lfs.2024.123239","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T13:16:39Z","timestamp":1732022199000},"page":"123239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The role of organic anion transport peptides in cyclophosphamide-induced hepatotoxicity in high-fat diet mice"],"prefix":"10.1016","volume":"359","author":[{"given":"Tianyi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.lfs.2024.123239_bb0005","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.3390\/ijerph17155294","article-title":"Are the Chinese moving toward a healthy diet? Evidence from macro data from 1961 to 2017","volume":"17","author":"Han","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.lfs.2024.123239_bb0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12966-021-01118-7","article-title":"Longitudinal trajectories of diet quality and subsequent mortality among Chinese adults: results from the China health and nutrition survey 1997-2015","volume":"18","author":"Liu","year":"2021","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"issue":"6","key":"10.1016\/j.lfs.2024.123239_bb0015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.chom.2022.03.030","article-title":"High-fat diet disrupts REG3\u03b3 and gut microbial rhythms promoting metabolic dysfunction","volume":"30","author":"Frazier","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.lfs.2024.123239_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104634","article-title":"The health effect of probiotics on high-fat diet-induced cognitive impairment, depression and anxiety: a cross-species systematic review","volume":"136","author":"Lof","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"12","key":"10.1016\/j.lfs.2024.123239_bb0025","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3390\/nu11123067","article-title":"Nonalcoholic fatty liver disease induced by high-fat diet in C57bl\/6 models","volume":"11","author":"Recena Aydos","year":"2019","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.lfs.2024.123239_bb0030","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.7150\/thno.56157","article-title":"High fat diet, gut microbiome and gastrointestinal cancer","volume":"11","author":"Tong","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.lfs.2024.123239_bb0035","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1039\/D1FO03952K","article-title":"N-acetylcysteine alleviates high fat diet-induced hepatic steatosis and liver injury via regulating the intestinal microecology in mice","volume":"13","author":"Ding","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.lfs.2024.123239_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101635","article-title":"Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy","volume":"36","author":"Gao","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2024.123239_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.108894","article-title":"Vitamin D ameliorates high-fat-diet-induced hepatic injury via inhibiting pyroptosis and alters gut microbiota in rats","volume":"705","author":"Zhang","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"issue":"9","key":"10.1016\/j.lfs.2024.123239_bb0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00011-020-01373-7","article-title":"Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease","volume":"69","author":"Ekta","year":"2020","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.lfs.2024.123239_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123239_bb0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12944-019-1063-y","article-title":"Effect of lipid metabolism disorder on liver function in patients with malignant tumors after chemotherapy: a case-control study","volume":"18","author":"Sun","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.lfs.2024.123239_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120671","article-title":"Piracetam attenuates cyclophosphamide-induced hepatotoxicity in rats: amelioration of necroptosis, pyroptosis and caspase-dependent apoptosis","volume":"303","author":"Mostafa","year":"2022","journal-title":"Life Sci."},{"year":"2017","series-title":"In LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","author":"Cyclophosphamide","key":"10.1016\/j.lfs.2024.123239_bb0070"},{"issue":"11","key":"10.1016\/j.lfs.2024.123239_bb0075","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2165\/00003088-200544110-00003","article-title":"Clinical pharmacokinetics of cyclophosphamide","volume":"44","author":"De Jonge","year":"2005","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.lfs.2024.123239_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2012.02.004","article-title":"Oxazaphosphorine bioactivation and detoxification the role of xenobiotic receptors","volume":"2","author":"Wang","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.lfs.2024.123239_bb0085","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/03602530500364023","article-title":"Metabolism and transport of oxazaphosphorines and the clinical implications","volume":"37","author":"Zhang","year":"2005","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.lfs.2024.123239_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.04.018","article-title":"Drugs and hepatic transporters: a review","volume":"154","author":"Jetter","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.lfs.2024.123239_bb0095","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.2741\/3527","article-title":"Hepatobiliary transporters in the pharmacology and toxicology of anticancer drugs","volume":"14","author":"Marin","year":"2009","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.lfs.2024.123239_bb0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/clpt.2013.74","article-title":"Emerging transporters of clinical importance: an update from the International Transporter Consortium","volume":"94","author":"Hillgren","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.lfs.2024.123239_bb0105","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2024.123239_bb0110","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2215\/CJN.08170719","article-title":"A post hoc analysis of statin use in tolvaptan autosomal dominant polycystic kidney disease pivotal trials","volume":"15","author":"Shoaf","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123239_bb0115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.107.018747","article-title":"Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer","volume":"36","author":"Morgan","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"9","key":"10.1016\/j.lfs.2024.123239_bb0120","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/jps.22641","article-title":"Transcriptional regulation of organic anion transporting polypeptide SLCO4C1 as a new therapeutic modality to prevent chronic kidney disease","volume":"100","author":"Suzuki","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.123239_bb0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1124\/jpet.113.205369","volume":"347","author":"Bodeman","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.lfs.2024.123239_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/dmd.107.016907","article-title":"Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta","volume":"36","author":"Le Vee","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.lfs.2024.123239_bb0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/17425255.2017.1253679","article-title":"The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions","volume":"13","author":"Kovacsics","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.lfs.2024.123239_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115039","article-title":"Elucidation of OATP1B1 and 1B3 transporter function using transgenic rodent models and commonly known single nucleotide polymorphisms","volume":"399","author":"Choudhuri","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123239_bb0145","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40264-018-0743-2","article-title":"Drug-induced liver injury: highlights of the recent literature","volume":"42","author":"Real","year":"2019","journal-title":"Drug Saf."},{"issue":"24","key":"10.1016\/j.lfs.2024.123239_bb0150","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.3748\/wjg.v21.i24.7427","article-title":"Liver fibrosis markers of nonalcoholic steatohepatitis","volume":"21","author":"Enomoto","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2024.123239_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.156668","article-title":"Polystyrene microplastics exacerbated liver injury from cyclophosphamide in mice: insight into gut microbiota","volume":"840","author":"Wen","year":"2022","journal-title":"Sci. Total Environ."},{"issue":"12","key":"10.1016\/j.lfs.2024.123239_bb0160","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/pharmaceutics11120624","article-title":"Impact of viral inflammation on the expression of renal drug transporters in pregnant rats","volume":"11","author":"Karimian Pour","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.lfs.2024.123239_bb0165","first-page":"1","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.lfs.2024.123239_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109199","article-title":"High fat diet-triggered non-alcoholic fatty liver disease: a review of proposed mechanisms","volume":"330","author":"Lian","year":"2020","journal-title":"Chem. Biol. Interact."},{"year":"2023","series-title":"In LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","author":"Antineoplastic Agents","key":"10.1016\/j.lfs.2024.123239_bb0175"},{"issue":"6","key":"10.1016\/j.lfs.2024.123239_bb0180","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/biom12060824","article-title":"NAFLD: mechanisms, treatments, and biomarkers","volume":"12","author":"Nassir","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.lfs.2024.123239_bb0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-981-13-7647-4_5","article-title":"Transporter-mediated drug-drug interactions and their significance","volume":"1141","author":"Liu","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2024.123239_bb0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-981-13-7647-4_3","article-title":"SLC family transporters","volume":"1141","author":"Liu","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2024.123239_bb0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-981-13-7647-4_6","article-title":"Roles of hepatic drug transporters in drug disposition and liver toxicity","volume":"1141","author":"Pan","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.lfs.2024.123239_bb0200","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/cpt.1360","article-title":"Clinical aspects of transporter-mediated drug-drug interactions","volume":"105","author":"Gessner","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.lfs.2024.123239_bb0205","first-page":"328","article-title":"HMG-CoA reductase inhibitors (statins) and their drug interactions involving CYP enzymes, P-glycoprotein and OATP transporters-an overview","volume":"22","author":"Balasubramanian","year":"2021","journal-title":"Curr. Drug Metab."},{"issue":"3","key":"10.1016\/j.lfs.2024.123239_bb0210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"International Transporter Consortium","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.lfs.2024.123239_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/bdd.1823","article-title":"Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption","volume":"34","author":"Shitara","year":"2013","journal-title":"Biopharm. Drug Dispos."},{"issue":"4","key":"10.1016\/j.lfs.2024.123239_bb0220","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","article-title":"The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy","volume":"78","author":"Ahlmann","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2-3","key":"10.1016\/j.lfs.2024.123239_bb0225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0300-483X(98)00081-X","article-title":"Ethanol does not increase the hepatotoxicity of cocaine in primary rat hepatocyte culture","volume":"129","author":"Figliomeni","year":"1998","journal-title":"Toxicology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524008294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524008294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T12:06:12Z","timestamp":1738152372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524008294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"alternative-id":["S0024320524008294"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123239","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of organic anion transport peptides in cyclophosphamide-induced hepatotoxicity in high-fat diet mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123239"}}